Search

Issue
Title
Authors
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
Zhilyakova V.V.
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Melnikov V.D.
CAR NK-сells for the treatment of hematological malignancies: A review
Gribkova I.V.
Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yudina E.V.
International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review)
Levashov A.S., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V.A., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadyrov S.U., Polyakov V.G.
Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study
Gameeva E.V., Stepanovna A.M., Khoronenko V.E., Gridnev O.V., Sviridov S.V., Shestopalov A.E.
Can musical interventions benefit patients with cancer?
Razumovskaya E.A.
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
Triple-negative breast cancer: new options for systemic targeted therapy. A review
Andreev D.A., Zavyalov A.A.
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)
Staroverova T.A.
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M.I., Turupaev K.A., Kalinin S.A.
The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial
Volchegorskii I.A., Vazhenin A.V., Alekseeva A.P.
Creating a story on the pages of a book about diffuse B-large cell lymphoma
Editorial B.
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report
Gushchina E.E., Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Khayrullina L.S., Lunin V.V., Fedenko A.A.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin R.N.
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I.V., Chubenko V.A.
How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review
Zhukova L.G., Bordin D.S., Dubtsova E.A., Ilin M.A., Kiriukova M.A., Feoktistova P.S., Egorov V.I.
Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON
Tryakin A.A., Fedyanin M.Y., Moiseenko F.V., Mironov O.V., Stroyakovskiy D.L., Sokolov N.I., Orlova S.A., Mantsyrev E.O., Sultanbaev A.V., Teterich A.A., Babina K.G., Yukalchuk D.Y., Borzyanitsa S.M., Isyangulova A.Z., Saidullaeva A.F., Chernova Y.A., Bobrova E.A., Fadeeva N.V., Chobanu D.Y.
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Modern strategy of treatment of patients with retroperitoneal sarcomas: A review
Stilidi I.S., Nikulin M.P., Kalinin O.E., Abgiarian M.G., Vashakmadze L.V., Fainshtein I.A., Arkhiri P.P., Salimova A.A.
Dermatological toxicity in the treatment of malignant tumors in children: A review
Belysheva T.S., Shatokhina E.A., Komarova A.D.
Radiation injuries of organs and tissues: mechanisms of occurrence, methods of prevention and treatment: A review
Balaeva D.A., Romanov D.S., Trofimova O.P., Gadzhibabaeva Z.Z., Gorchak Y.Y., Gariaev G.A.
Radiation induced skin reactions in primary cutaneous lymphoma patients: A review
Ilyin N.V., Vinogradova Y.N., Zaslavskiy D.V., Maria M.I.
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy
Editorial B.
Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Lienhard D.A.
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E.A., Bialik T.E., Zaritskii A.I., Iseber L., Kaplanov K.D., Lopatkina T.N., Lugovskaia S.A., Mukhortova O.V., Osmanov E.A., Poddubnaya I.V., Samoilova O.S., Stadnik E.A., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review
Ivanov A.I., Popov V.A., Burmistrov M.V.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.V.
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Semiglazov V.F., Poddubnaya I.V.
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M.I., Nuriev R.I., Rozhkov A.A., Semenkov A.V., Bagmet N.N., Boroda A.M.
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.S.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
Combined and complex treatment options for patients with operable rectal cancer
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy
Bozhok A.A., Semiglazov V.F., Kletsel' A.E., Arzumanov A.S., Ivanova O.A., Semiglazov V.V.
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I.P., Gordeeva O.O., Manukian M.S.
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Gordiev M.G., Kononets P.V., Akhmedov B.B., Maevskaia J.N.
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.V.
Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0
Manikhas A.G., Grinev I.A., Oganesian A.S., Chikrizov S.I., Manikhas G.M.
First results of the Russian multicenter epidemiology project on the malignant gliomas
Smolin A.V., Bekyashev A.H., Kobyakov G.L., Sharabura T.M., Mufazalov F.F., Kanischeva N.V., Bumagina V.O.
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
Bialik T.E., Vorob'ev V.I., Ionin V.A., Ysebaert L., Kaplanov K.D., Mendeleeva L.P., Nikitin E.A., Ptushkin V.V., Samoilova O.S., Stadnik E.A.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.V.
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
Modern radiation therapy in part of treatment primary mediastinal (thymic) B-large cell lymphoma (results of 131 patients treated at N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation)
Trofimova O.P., Zavodnova I.Z., Tumyan G.S., Pryamikova Y.I., Volkova N.V., Zaichenko O.S., Nazarenko A.V.
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.V.
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy
Kolyadina I.V., Poddubnaya I.V., Pavlikova O.A., Komov D.V.
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
Keratoacanthoma: possible management approaches. Case reports
Teterin K.A., Kizhaev Y.E., Bolotova N.P.
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
RADIOTHERAPY AS THE ONLY TREATMENT IN CASE OF TONGUE CANCER PATIENTS
Garbuzov M.I.
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
Rasner P.I., Pushkar' D.Y., Govorov A.V.
Targetnaya terapiya raka pochki
Alekseev B.Y., Shegay P.V.
Lekarstvennaya terapiya solidnykh opukholey s metastazami v golovnom mozge
Konstantinova M.M.
Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze
Nikitin E.A., Malakho S.G., Biderman B.V., Poltaraus A.B., Sudarikov A.B.
Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)
Kaprin A.D., Voronin E.E., Rassokhin V.V., Rozenberg V.V., Nekrasova A.V., Falaleeva N.A., Ivanov S.A., Grivtsova L.Y.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.V.
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S.S., Dem'yanova G.A.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Modern options in personalized therapy of metastatic cutaneous melanoma
Protsenko S.A., Novik A.V., Akhaeva Z.Y., Zhabina A.S., Imyanitov E.N., Semenova A.I.
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.V.
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results
Garbuzov M.I.
Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey
Nikulin M.P., Stilidi I.S.
Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii
Konstantinova M.M.
Znachenie luchevoy terapii v lechenii generalizovannykh nekhodzhkinskikh limfom (IV stadiya)
Kharchenko V.P., Pan'shin G.A., Sotnikov V.M., Datsenko P.V., Smol'tsova N.N., Nikolaeva E.V.
Nekhodzhkinskie limfomy mochepolovoy sistemy
Bogdanov A.N., Maksimov A.G., Anosov N.A., Krivolapov Y.A.
Opyt primeneniya Regional'noy programmy v g. Krasnodare
Mitashok I.S.
Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
Protasova A.E., Strakh L.V., Lando E.I., Sidorkina E.V.
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Reutova E.V., Ardzinba M.S., Arzumanian A.L.
Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children
Shervashidze M.A., Valiev T.T., Batmanova N.A., Tupitsyn N.N., Serebryakova I.N.
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options
Artamonova E.V., Manzyuk L.V.
Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Trofimova O.P., Tkachev S.I., Ivanov S.M., Utkina V.L., Cheban O.I., Glebovskaya V.V.
Angiogenesis as a target for cancer therapy
Imyanitov E.N.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Lichinitser M.R., Semenov N.N.
Novye vozmozhnosti targetnoy terapii neyropaticheskoy boli v onkologii
Abuzarova G.R., Prokhorov B.M., Sokolenov A.S., Shakhnovich E.B.
Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey
Imyanitov E.N.
Rol' luchevoy terapii v lechenii bol'nykh ekstranodal'nymi zlokachestvennymi limfomami
Il'in N.V., Vinogradova Y.N., Nikolaeva E.N., Ivanova E.I.
Limfoma iz kletok mantiynoy zony: klinicheskie osobennosti i vozmozhnosti terapii
Lorie Y.Y.
Analiz rezul'tatov vnedreniya Regional'noy rossiyskoy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy v Voronezhskom oblastnom klinicheskom onkologicheskom dispansere
Chevardov N.I., Tolstykh L.V., Puzakov K.G., Potapov Y.N.
Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
Ognerubov N.A., Barsukov S.V.
Vulvar cancer: brain metastases. Clinical observation
Ognerubov N.A., Antipova T.S., Kamneva N.A.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
1 - 100 of 173 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies